188 related articles for article (PubMed ID: 34319110)
1. Positron Emission Tomography Imaging of Autotaxin in Thyroid and Breast Cancer Models Using [
Litchfield M; Wuest M; Glubrecht D; Briard E; Auberson YP; McMullen TPW; Brindley DN; Wuest F
Mol Pharm; 2021 Sep; 18(9):3352-3364. PubMed ID: 34319110
[TBL] [Abstract][Full Text] [Related]
2. [
Briard E; Joshi AD; Shanmukhappa S; Ilovich O; Auberson YP
ChemMedChem; 2019 Aug; 14(16):1493-1502. PubMed ID: 31273951
[TBL] [Abstract][Full Text] [Related]
3. [
Ebrahimi E; Wuest M; Kaur J; Bhardwaj A; Gade NR; Wuest F
Bioorg Med Chem Lett; 2023 Jun; 90():129345. PubMed ID: 37217023
[TBL] [Abstract][Full Text] [Related]
4. Imaging Autotaxin
Deng X; Salgado-Polo F; Shao T; Xiao Z; Van R; Chen J; Rong J; Haider A; Shao Y; Josephson L; Perrakis A; Liang SH
J Med Chem; 2021 Oct; 64(20):15053-15068. PubMed ID: 34662125
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
[TBL] [Abstract][Full Text] [Related]
7. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
8. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive imaging of tumors by monitoring autotaxin activity using an enzyme-activated near-infrared fluorogenic substrate.
Madan D; Ferguson CG; Lee WY; Prestwich GD; Testa CA
PLoS One; 2013; 8(11):e79065. PubMed ID: 24278115
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.
Dong YL; Duan XY; Liu YJ; Fan H; Xu M; Chen QY; Nan Z; Wu H; Deng SJ
Inflammation; 2019 Oct; 42(5):1530-1541. PubMed ID: 31102124
[TBL] [Abstract][Full Text] [Related]
11. Radiosynthesis and Biological Evaluation of [
Litchfield M; Wuest M; Glubrecht D; Wuest F
Mol Pharm; 2020 Jan; 17(1):251-261. PubMed ID: 31816246
[TBL] [Abstract][Full Text] [Related]
12. PET Imaging of
Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
[TBL] [Abstract][Full Text] [Related]
13. Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.
Brindley DN; Tang X; Meng G; Benesch MGK
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824846
[TBL] [Abstract][Full Text] [Related]
14. Autotaxin inhibitors: a patent review (2012-2016).
Nikolaou A; Kokotou MG; Limnios D; Psarra A; Kokotos G
Expert Opin Ther Pat; 2017 Jul; 27(7):815-829. PubMed ID: 28447479
[TBL] [Abstract][Full Text] [Related]
15. The Expression Regulation and Biological Function of Autotaxin.
Zhang X; Li M; Yin N; Zhang J
Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
[TBL] [Abstract][Full Text] [Related]
16. [
Clemente GS; Antunes IF; Sijbesma JWA; van Waarde A; Lammertsma AA; Dömling A; Elsinga PH
Mol Pharm; 2021 Sep; 18(9):3378-3386. PubMed ID: 34351158
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a novel, cell-based autotaxin assay.
Dobersalske C; Grundmann M; Timmermann A; Theisen L; Kölling F; Harris RC; Fuerstner C; Becker MS; Wunder F
Anal Biochem; 2021 Oct; 630():114322. PubMed ID: 34343482
[TBL] [Abstract][Full Text] [Related]
18. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
19. [
Hu F; Gong C; Gai Y; Jiang D; Liu Q; Wang S; Hu M; Pi R; Shu H; Hu J; Lan X
Mol Pharm; 2021 Sep; 18(9):3544-3552. PubMed ID: 34482695
[TBL] [Abstract][Full Text] [Related]
20. Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms.
Toyohara T; Yoshida M; Miyabe K; Hayashi K; Naitoh I; Kondo H; Hori Y; Kato A; Kachi K; Asano G; Sahashi H; Adachi A; Kuno K; Kito Y; Matsuo Y; Kataoka H
Cancer Sci; 2023 Dec; 114(12):4571-4582. PubMed ID: 37770812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]